Corning extends reach of Epic technology

Published: 7-Dec-2010
Research & Development Finance

Collaborates with Advinus to bring label-free detection technology to India


Advinus Therapeutics, a research-based pharmaceutical company promoted by the Indian Tata Group, and Corning Incorporated are to collaborate to bring Corning’s Epic label-free detection technology to India.

The collaboration will enable Advinus to use Corning’s technology to enhance its drug discovery capabilities and provide assay development and screening services to companies both in India and abroad.

Corning says its Epic technology combines biochemical detection and cellular analysis on a single label-free platform to enable a better understanding of biological activity for a range of research applications. It helps identify targets, pathways, and interactions, providing more biologically relevant data to the drug discovery process, the firm says.

‘We believe this is an important step forward in making our Epic technology more accessible to life science researchers worldwide,’ said Ron Verkleeren, director of Advanced Life Sciences at Corning.

Kasim Mookhtiar, chief scientific officer of Advinus, added: ‘This collaboration on Corning’s Epic technology emphasises Advinus’ commitment to set up unique pharma r&d services in India and to explore new and cutting-edge technologies to enhance our drug discovery capabilities.’

  • Companies:
  • Corning
  • Advinus Therapeutics
See more

You may also like

Manufacturing

Curia reveals continuous-flow collaboration with Corning

Read more
Continuous flow chemistry is critical for the development and manufacture of pharmaceutical intermediates and APIs

Trending Articles

  1. ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year The award recognises employers that create an outstanding experience for employees
  2. Rapid increase in purchasing teams expected at CPHI North America Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
  3. Wacker Chemical Corporation promotes Christoph Kowitz to President of US subsidiary The position originally held by David Willhoit is a promotion from Christoph's six year tenure as the Head of Corporate R&D
  4. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
  5. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Curia reveals continuous-flow collaboration with Corning

Continuous flow chemistry is critical for the development and manufacture of pharmaceutical intermediates and APIs
Packaging

Gerresheimer to sell glass tubing business to Corning for €196m

Companies plan to set up a joint venture to accelerate innovation in pharmaceutical glass packaging
Manufacturing

Corning to acquire Plaslab

Adds sampling, testing and analysis consumables to life sciences portfolio
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Ardena's nanomedicines facility marks expansion with first GMP approval

The EUR €20m expansion to the nanomedicines facility at Pivot Park has achieved operational status by the Dutch Healthcare Authority
Research & Development

Compact process thermostat for efficient temperature control in the laboratory

The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
Drug Delivery

Adult vaccination programmes deliver significant socio-economic benefits, study finds

The study shows that adult immunisation programmes return 19x their initial investment, which could ease the pressure on health systems
Subscribe now